These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2698888)

  • 1. Comparative bioavailability of two brands of carbamazepine. Reply from the authors.
    Bhatt AD
    J Assoc Physicians India; 1989 Sep; 37(9):619-20. PubMed ID: 2698888
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability with two brands of carbamazepine-Tegretol and Mazetol in healthy volunteers.
    Bhatia SC; Bhatt AD; Bakshi RJ; Revankar SN; Bharucha ED; Doshi KJ; Nagarsenkar SS; Shah NN; Marthak KV; Bolar HV
    J Assoc Physicians India; 1988 Oct; 36(10):611-2. PubMed ID: 3220811
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative bioavailability of Mazetol and Tegretol.
    Batham AK
    J Assoc Physicians India; 1989 Jun; 37(6):413-4. PubMed ID: 2592338
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of absorption rate and bioavailability of two brands of carbamazepine.
    Revankar SN; Desai ND; Bhatt AD; Bolar HV; Sane SP; Gupta C; Kamat DV
    J Assoc Physicians India; 1999 Jul; 47(7):699-702. PubMed ID: 10778590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative bioavailability of four Carbamazepine tablet formulations available in the Kenyan market.
    Oluka MO; Mitema ES; Kibwage IO; Kwasa TO; Kokwaro GO
    East Afr Med J; 1996 May; 73(5):323-6. PubMed ID: 8756037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of carbamazepine 200 mg tablets.
    Kibwage IO; Nguyo M
    East Afr Med J; 1993 Aug; 70(8):512-4. PubMed ID: 8261973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bioavailability of two brands of rifampicin.
    Bhatt AD; Revankar SN
    J Assoc Physicians India; 1999 Jul; 47(7):752. PubMed ID: 10778615
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative bioavailability studies on some brands of ampicillin capsules.
    Ogunbona FA; Akanni AO
    Pharmazie; 1985 Jul; 40(7):479. PubMed ID: 4048254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of two carbamazepine tablets.
    Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BEQUIV interactive microcomputer program for testing equivalence in two-group comparative bioavailability trials.
    Durisová M; Trnovec T
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):129-33. PubMed ID: 3361979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic vs. branded carbamazepine.
    Aita JF
    Nebr Med J; 1988 Nov; 73(11):322-3. PubMed ID: 3200346
    [No Abstract]   [Full Text] [Related]  

  • 13. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
    Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
    Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the bioavailability of a carbamazepine slow-release formulation.
    Retzow A; Schürer M; Schulz HU
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):557-60. PubMed ID: 9455713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of two formulations of azithromycin.
    Gulati R; Tripathi CD; Chandra D
    J Assoc Physicians India; 2000 Jun; 48(6):606-8. PubMed ID: 11273540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.
    Wangemann M; Retzow A; Evers G; Mazur D; Schug B; Blume H
    Arzneimittelforschung; 1998 Dec; 48(12):1131-7. PubMed ID: 9893926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and central side effects of different carbamazepine tablets.
    Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):226-32. PubMed ID: 3997307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of carbamazepine:beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets.
    Koester LS; Bertuol JB; Groch KR; Xavier CR; Moellerke R; Mayorga P; Dalla Costa T; Bassani VL
    Eur J Pharm Sci; 2004 Jun; 22(2-3):201-7. PubMed ID: 15158905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of the bioavailability/bioequivalence controversy.
    Gottschalk LA
    J Clin Psychiatry; 1986 Sep; 47 Suppl():3-5. PubMed ID: 3528133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.